arXiv subjects

Guilherme C. Oliveira

Publications and source records attributed to Guilherme C. Oliveira.

4 recordsLinked to original sources

arXiv2026

SDARE-Bench: Evaluating Large Language Models on Conversational Stigma Detection and Response in Dyadic and Group Dialogue

Large Language Models (LLMs) are increasingly used in advice seeking and decision making that may affect social judgements. Despite stigma's profound effects on people and communities, benchmarks remain scarce. Existing general-domain evaluations typically rely on static prompts and fixed-format tasks, overlooking conversational contexts and audience effects in everyday communication. To address these gaps, we introduce SDARE-Bench, the first scenario-based benchmark evaluating both stigma detection and open-ended response generation in LLMs, comprising 1,138 dyadic queries and 1,388 group dialogue. Empirical results across 8 LLMs consistently demonstrate poor identification of stigma components, especially in group dialogues. In open-ended response generation, stigma expression was substantially higher in group settings than in dyadic, with weaker resistance to stigma and more unrealistic advice. Responses were evaluated using a classifier trained on 1,392 human annotated responses. In constructed group pressure settings, stigma expression rates further increased to a striking average of 97.5%. Our findings identify stigma response as a recurring LLM safety vulnerability, especially in socially complex conversational contexts.

cs.CL↗

arXiv2026

AnchorSIPS: A Synthetic Dataset and Evaluation Resource for Evidence-Supported Psychosis-Risk Symptom Measurement

Progress on AI for psychosis-risk assessment is limited by a data-access bottleneck. Real clinical interviews are difficult to share because of privacy, governance, and consent constraints. We present AnchorSIPS, a synthetic dataset of 10K structured psychosis-risk interviews with transcript-grounded measurement targets. Each interview is modeled on Mini-SIPS, a clinician-administered psychosis-risk interview. It captures history, 24 symptom questions, follow-up evidence for items the patient affirms, decisions about delusion-like symptoms (unusual beliefs), hallucination-like symptoms (unusual perceptions), and disorganized communication, exclusion of clear psychotic-level symptoms ("frank psychosis"), and a final attenuated psychosis syndrome (APS) diagnosis, a high-risk state of milder or early psychotic symptoms. The APS diagnosis is not a standalone label. It depends on earlier endorsements, supporting follow-up details, symptom-class decisions, and the frank-psychosis check. Every intermediate decision is anchored to its supporting transcript turns. AnchorSIPS is generated by a plan-then-realize pipeline. A hidden case sheet specifies the patient's clinical state, a deterministic planner fixes the interview structure, and an LLM realizes only the patient utterances under validation and bounded repair. Fixing labels and structure before generation avoids the inter-turn inconsistencies typical of multi-turn LLM dialogue. Across seven LLM baselines, models recover coarse decisions but fail to extract follow-up details or cite supporting transcript turns, so final-label performance overstates interview competence. AnchorSIPS is intended for research on evidence extraction, transcript-grounded measurement, and uncertainty under partial disclosure.

cs.CL↗

arXiv2026

CHiRPE: A Step Towards Real-World Clinical NLP with Clinician-Oriented Model Explanations

The medical adoption of NLP tools requires interpretability by end users, yet traditional explainable AI (XAI) methods are misaligned with clinical reasoning and lack clinician input. We introduce CHiRPE (Clinical High-Risk Prediction with Explainability), an NLP pipeline that takes transcribed semi-structured clinical interviews to: (i) predict psychosis risk; and (ii) generate novel SHAP explanation formats co-developed with clinicians. Trained on 944 semi-structured interview transcripts across 24 international clinics of the AMP-SCZ study, the CHiRPE pipeline integrates symptom-domain mapping, LLM summarisation, and BERT classification. CHiRPE achieved over 90% accuracy across three BERT variants and outperformed baseline models. Explanation formats were evaluated by 28 clinical experts who indicated a strong preference for our novel concept-guided explanations, especially hybrid graph-and-text summary formats. CHiRPE demonstrates that clinically-guided model development produces both accurate and interpretable results. Our next step is focused on real-world testing across our 24 international sites.

cs.CL↗

arXiv2024

Robust deep learning for eye fundus images: Bridging real and synthetic data for enhancing generalization

Deep learning applications for assessing medical images are limited because the datasets are often small and imbalanced. The use of synthetic data has been proposed in the literature, but neither a robust comparison of the different methods nor generalizability has been reported. Our approach integrates a retinal image quality assessment model and StyleGAN2 architecture to enhance Age-related Macular Degeneration (AMD) detection capabilities and improve generalizability. This work compares ten different Generative Adversarial Network (GAN) architectures to generate synthetic eye-fundus images with and without AMD. We combined subsets of three public databases (iChallenge-AMD, ODIR-2019, and RIADD) to form a single training and test set. We employed the STARE dataset for external validation, ensuring a comprehensive assessment of the proposed approach. The results show that StyleGAN2 reached the lowest Frechet Inception Distance (166.17), and clinicians could not accurately differentiate between real and synthetic images. ResNet-18 architecture obtained the best performance with 85% accuracy and outperformed the two human experts (80% and 75%) in detecting AMD fundus images. The accuracy rates were 82.8% for the test set and 81.3% for the STARE dataset, demonstrating the model's generalizability. The proposed methodology for synthetic medical image generation has been validated for robustness and accuracy, with free access to its code for further research and development in this field.

eess.IV↗